Increased plasma ammonia may inhibit cellular release of branched-chain amino acids in systemic portal encephalopathy.
Plasma amino acid patterns were determined before and after hemofiltration (HF) and hemodialysis (HD) in 6 patients with portal systemic encephalopathy (PSE) and compared with the plasma AA patterns of 16 patients with chronic renal failure (CRF) treated either by HF or HD. The branched-chain amino acids (BCAA) increased paradoxically in PSE patients during HF but not with HD. There were no differences in BCAA's with HF as compared to HD in the CRF patients. The amount of amino acids lost was the same with both treatment modalities and in both patient groups. Much of the amino acids lost were released from the intracellular space. The BCAA release was significantly higher in PSE patients during HF. No correlation was found between plasma insulin, glucagon, and cortisol levels and BCAA release. An inverse correlation was found between the amount of BCAA's released from the intracellular space and the plasma ammonia levels. It is suggested that a selective cellular transport mechanism for BCAA exists which is inhibited by high plasma ammonia levels in PSE.
D000328:Adult; D000596:Amino Acids / Q000097:blood; D000597:Amino Acids, Branched-Chain / Q000172:deficiency*; D000641:Ammonia / Q000097:blood*; D001692:Biological Transport; D001769:Blood; D003131:Combined Modality Therapy; D005110:Extracellular Space / Q000378:metabolism; D005260:Female; D006501:Hepatic Encephalopathy / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007424:Intracellular Fluid / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000379:methods; D014462:Ultrafiltration / Q000379:methods
D000596:Amino Acids; D000597:Amino Acids, Branched-Chain; D000641:Ammonia